
About
This app empowers users to manage their health by providing guidance, education, and reminders for routine health maintenance and disease monitoring. It facilitates self-monitoring and screening tests, aiming to reduce the need for frequent clinic visits. The app prioritizes the security and confidentiality of user information.
What's New in CF@Home
1.1.0
September 26, 2023
Bug fixes
Developer apps
FAQ
What is CF@Home?
CF@Home is a medical app designed to help users manage their health at home. It provides guidance, education, and reminders for routine health maintenance and disease monitoring, aiming to empower users in their own care.
Is CF@Home free to use?
Yes, CF@Home is available for free. The app does not have any associated costs for download or use, and it does not feature in-app purchases or advertisements.
What devices does CF@Home support?
CF@Home is compatible with iOS devices, including iPhone, iPad, and iPod. It is designed for users within the Apple ecosystem.
How often is CF@Home updated?
The latest version of CF@Home is 1.1.0, which was last updated on September 26, 2023. This indicates a relatively recent update, suggesting ongoing development and support.
Does CF@Home provide medical advice?
No, CF@Home explicitly states that it does not provide medical advice, diagnosis, or treatment. Users are advised to always seek the advice of their physician or other qualified health provider for any medical concerns.
How is my information secured in CF@Home?
The app emphasizes that it carefully ensures the security and confidentiality of user information. Anything shared within the app is stored securely and managed with care.
What is the age rating for CF@Home?
CF@Home has an age rating of 4+. This suggests it is suitable for a wide range of users, though its primary function is for health management.
What is the user sentiment for CF@Home?
Based on the available data, CF@Home has a perfect rating of 5.0 stars from 2 ratings. This indicates very positive user sentiment among its current users.


